Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapyYun Liu, Yongzhong Liu|Science Advances|2024Cited by 14
UBE2D1 as a key biomarker in systemic juvenile idiopathic arthritis: a new perspective on diagnosis and disease activity assessmentQiang Luo, Xuemei Tang, Dawei Liu et al.|Arthritis Research & Therapy|2025Cited by 4